251,044
------- -------
Operating income
(loss) (1,531) 8,278
Interest expense 9,398 12,081
Interest income (27) (228)
Foreign exchange
loss (gain), net 3,174 (3,013)
----- ------
Loss before income
taxes (14,076) (562)
Income tax expense
(benefit) (3,668) 2,710
------ -----
Net loss $(10,408) $(3,272)
-------- -------
Pregis Holding II Corporation
Consolidated Statements of Cash Flows
Unaudited
(dollars in thousands)
Three Months Ended March 31,
----------------------------
2009 2008
---- ----
Operating activities
Net loss $(10,408) $(3,272)
Adjustments to reconcile
net loss to cash provided
by operating activities:
Depreciation and
amortization 11,471 13,540
Deferred income taxes (4,056) 1,810
Unrealized foreign
exchange loss (gain) 3,466 (2,972)
Amortization of
deferred financing
costs 594 594
Gain on disposal of
property, plant and
equipment (211) -
Stock compensation
expense 433 184
Changes in operating assets
and liabilities, net
of effects o
'/>"/>SOURCE Pregis Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1.
Pregis Corporation Appoints New President of Protective Packaging North America2.
Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results3.
Pregis Announces Fouth Quarter and Full Year 2007 Financial Results4.
Pregis Announces First Quarter 2008 Financial Results5.
Pregis Announces Second Quarter 2008 Financial Results6.
Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results7.
Pregis Announces Third Quarter 2008 Financial Results8.
Pregis Announces Investor Conference Call to Review Fourth Quarter and Full Year 2008 Financial Results9.
Pregis Announces Fourth Quarter and Full Year 2008 Financial Results10.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness11.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael